{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T17:37:31Z","timestamp":1784309851485,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,20]],"date-time":"2017-12-20T00:00:00Z","timestamp":1513728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,12,20]],"date-time":"2017-12-20T00:00:00Z","timestamp":1513728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>People with fatty liver disease are at high risk of magnesium deficiency. Meanwhile, low magnesium status is linked to both chronic inflammation and insulin resistance. However, no study has investigated the association between intake of magnesium and risk of mortality due to liver diseases. We evaluated the association between total magnesium intake and mortality due to liver diseases in the Third National Health and Nutrition Examination Study (NHANES III) cohort, which included 13,504 participants who completed liver ultrasound examination for hepatic steatosis. Overall magnesium intake was associated with a reduced risk of mortality due to liver disease at borderline significance (P\u2009=\u20090.05). In fully-adjusted analyses, every 100\u2009mg increase in intake of magnesium was associated with a 49% reduction in the risk for mortality due to liver diseases. Although interactions between magnesium intake and alcohol use and hepatic steatosis at baseline were not significant (P\u2009&gt;\u20090.05), inverse associations between magnesium intake and liver disease mortality were stronger among alcohol drinkers and those with hepatic steatosis. Our findings suggest higher intakes of magnesium may be associated with a reduced risk of mortality due to liver disease particularly among alcohol drinkers and those with hepatic steatosis. Further studies are warranted to confirm the findings.<\/jats:p>","DOI":"10.1038\/s41598-017-18076-5","type":"journal-article","created":{"date-parts":[[2017,12,14]],"date-time":"2017-12-14T15:31:05Z","timestamp":1513265465000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Magnesium intake and mortality due to liver diseases: Results from the Third National Health and Nutrition Examination Survey Cohort"],"prefix":"10.1038","volume":"7","author":[{"given":"Lijun","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangzhu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8993-3186","authenticated-orcid":false,"given":"Edmond K.","family":"Kabagambe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghua","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosong","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifang","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5591-7575","authenticated-orcid":false,"given":"Martha J.","family":"Shrubsole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,20]]},"reference":[{"key":"18076_CR1","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1053\/j.gastro.2015.08.045","volume":"149","author":"AF Peery","year":"2015","unstructured":"Peery, A. F. et al. Burden of Gastrointestinal, Liver, and Pancreatic Diseases in the United States. Gastroenterology 149, 1731\u20131741.e3 (2015).","journal-title":"Gastroenterology"},{"key":"18076_CR2","doi-asserted-by":"crossref","unstructured":"GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Lond. Engl. 388, 1459\u20131544 (2016).","DOI":"10.1016\/S0140-6736(16)31012-1"},{"key":"18076_CR3","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.jhep.2012.12.005","volume":"58","author":"M Blachier","year":"2013","unstructured":"Blachier, M., Leleu, H., Peck-Radosavljevic, M., Valla, D.-C. & Roudot-Thoraval, F. The burden of liver disease in Europe: a review of available epidemiological data. J. Hepatol. 58, 593\u2013608 (2013).","journal-title":"J. Hepatol."},{"key":"18076_CR4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/aje\/kws448","volume":"178","author":"M Lazo","year":"2013","unstructured":"Lazo, M. et al. Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988\u20131994. Am. J. Epidemiol. 178, 38\u201345 (2013).","journal-title":"Am. J. Epidemiol."},{"key":"18076_CR5","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","volume":"116","author":"CA Matteoni","year":"1999","unstructured":"Matteoni, C. A. et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116, 1413\u20131419 (1999).","journal-title":"Gastroenterology"},{"key":"18076_CR6","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","volume":"50","author":"G Marchesini","year":"2001","unstructured":"Marchesini, G. et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50, 1844\u20131850 (2001).","journal-title":"Diabetes"},{"key":"18076_CR7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1586\/egh.11.21","volume":"5","author":"RC Harmon","year":"2011","unstructured":"Harmon, R. C., Tiniakos, D. G. & Argo, C. K. Inflammation in nonalcoholic steatohepatitis. Expert Rev. Gastroenterol. Hepatol. 5, 189\u2013200 (2011).","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"18076_CR8","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/jhep.2002.30690","volume":"35","author":"G Pagano","year":"2002","unstructured":"Pagano, G. et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatol. Baltim. Md 35, 367\u2013372 (2002).","journal-title":"Hepatol. Baltim. Md"},{"key":"18076_CR9","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S0002-9343(99)00271-5","volume":"107","author":"G Marchesini","year":"1999","unstructured":"Marchesini, G. et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am. J. Med. 107, 450\u2013455 (1999).","journal-title":"Am. J. Med."},{"key":"18076_CR10","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1053\/j.gastro.2016.02.035","volume":"150","author":"LE Nagy","year":"2016","unstructured":"Nagy, L. E., Ding, W.-X., Cresci, G., Saikia, P. & Shah, V. H. Linking Pathogenic Mechanisms of Alcoholic Liver Disease With Clinical Phenotypes. Gastroenterology 150, 1756\u20131768 (2016).","journal-title":"Gastroenterology"},{"key":"18076_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/nyas.12787","volume":"1353","author":"RM Carr","year":"2015","unstructured":"Carr, R. M. & Correnti, J. Insulin resistance in clinical and experimental alcoholic liver disease. Ann. N. Y. Acad. Sci. 1353, 1\u201320 (2015).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"18076_CR12","first-page":"969","volume":"21","author":"V Schinzari","year":"2015","unstructured":"Schinzari, V., Barnaba, V. & Piconese, S. Chronic hepatitis B virus and hepatitis C virus infections and cancer: synergy between viral and host factors. Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis. 21, 969\u2013974 (2015).","journal-title":"Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis."},{"key":"18076_CR13","first-page":"293","volume":"12","author":"RJ Wong","year":"2016","unstructured":"Wong, R. J. & Gish, R. G. Metabolic Manifestations and Complications Associated With Chronic Hepatitis C Virus Infection. Gastroenterol. Hepatol. 12, 293\u2013299 (2016).","journal-title":"Gastroenterol. Hepatol."},{"key":"18076_CR14","first-page":"58","volume":"107","author":"L Turecky","year":"2006","unstructured":"Turecky, L. et al. Serum magnesium levels in patients with alcoholic and non-alcoholic fatty liver. Bratisl. Lek. Listy 107, 58\u201361 (2006).","journal-title":"Bratisl. Lek. Listy"},{"key":"18076_CR15","first-page":"197","volume":"21","author":"AMP Romani","year":"2008","unstructured":"Romani, A. M. P. Magnesium homeostasis and alcohol consumption. Magnes. Res. 21, 197\u2013204 (2008).","journal-title":"Magnes. Res."},{"key":"18076_CR16","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1080\/07315724.1994.10718430","volume":"13","author":"RS Rivlin","year":"1994","unstructured":"Rivlin, R. S. Magnesium deficiency and alcohol intake: mechanisms, clinical significance and possible relation to cancer development (a review). J. Am. Coll. Nutr. 13, 416\u2013423 (1994).","journal-title":"J. Am. Coll. Nutr."},{"key":"18076_CR17","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/j.1530-0277.1986.tb05150.x","volume":"10","author":"EB Rink","year":"1986","unstructured":"Rink, E. B. Magnesium Deficiency in Alcoholism. Alcohol. Clin. Exp. Res. 10, 590\u2013594 (1986).","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"18076_CR18","doi-asserted-by":"publisher","first-page":"G57","DOI":"10.1152\/ajpgi.00153.2002","volume":"284","author":"A Young","year":"2003","unstructured":"Young, A., Cefaratti, C. & Romani, A. Chronic EtOH administration alters liver Mg2+ homeostasis. Am. J. Physiol. Gastrointest. Liver Physiol. 284, G57\u201367 (2003).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"18076_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2337\/db15-1028","volume":"65","author":"LMM Gommers","year":"2016","unstructured":"Gommers, L. M. M., Hoenderop, J. G. J., Bindels, R. J. M. & de Baaij, J. H. F. Hypomagnesemia in Type 2 Diabetes: A Vicious Circle? Diabetes 65, 3\u201313 (2016).","journal-title":"Diabetes"},{"key":"18076_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0925-4439(00)00018-1","volume":"1501","author":"C Malpuech-Brug\u00e8re","year":"2000","unstructured":"Malpuech-Brug\u00e8re, C. et al. Inflammatory response following acute magnesium deficiency in the rat. Biochim. Biophys. Acta 1501, 91\u201398 (2000).","journal-title":"Biochim. Biophys. Acta"},{"key":"18076_CR21","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.freeradbiomed.2006.04.008","volume":"41","author":"D Blache","year":"2006","unstructured":"Blache, D. et al. Long-term moderate magnesium-deficient diet shows relationships between blood pressure, inflammation and oxidant stress defense in aging rats. Free Radic. Biol. Med. 41, 277\u2013284 (2006).","journal-title":"Free Radic. Biol. Med."},{"key":"18076_CR22","first-page":"90","volume":"23","author":"H Rodriguez-Hernandez","year":"2010","unstructured":"Rodriguez-Hernandez, H., Cervantes-Huerta, M., Rodriguez-Moran, M. & Guerrero-Romero, F. Oral magnesium supplementation decreases alanine aminotransferase levels in obese women. Magnes. Res. 23, 90\u201396 (2010).","journal-title":"Magnes. Res."},{"key":"18076_CR23","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s00394-007-0655-x","volume":"46","author":"D Almoznino-Sarafian","year":"2007","unstructured":"Almoznino-Sarafian, D. et al. Magnesium and C-reactive protein in heart failure: an anti-inflammatory effect of magnesium administration? Eur. J. Nutr. 46, 230\u2013237 (2007).","journal-title":"Eur. J. Nutr."},{"key":"18076_CR24","first-page":"158","volume":"23","author":"FH Nielsen","year":"2010","unstructured":"Nielsen, F. H., Johnson, L. K. & Zeng, H. Magnesium supplementation improves indicators of low magnesium status and inflammatory stress in adults older than 51 years with poor quality sleep. Magnes. Res. 23, 158\u2013168 (2010).","journal-title":"Magnes. Res."},{"key":"18076_CR25","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1111\/j.1464-5491.2006.01852.x","volume":"23","author":"Y Song","year":"2006","unstructured":"Song, Y., He, K., Levitan, E. B., Manson, J. E. & Liu, S. Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: a meta-analysis of randomized double-blind controlled trials. Diabet. Med. J. Br. Diabet. Assoc. 23, 1050\u20131056 (2006).","journal-title":"Diabet. Med. J. Br. Diabet. Assoc."},{"key":"18076_CR26","first-page":"1","volume":"27","author":"RB Ervin","year":"2004","unstructured":"Ervin, R. B., Wang, C. Y., Wright, J. D. & Kennedy-Stephenson, J. Dietary intake of selected minerals for the United States population: 1999\u20132000. Adv Data. 27, 1\u20135 (2004).","journal-title":"Adv Data."},{"key":"18076_CR27","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1080\/07315724.2003.10719332","volume":"22","author":"TT Fung","year":"2003","unstructured":"Fung, T. T. et al. The association between magnesium intake and fasting insulin concentration in healthy middle-aged women. J. Am. Coll. Nutr. 22, 533\u2013538 (2003).","journal-title":"J. Am. Coll. Nutr."},{"key":"18076_CR28","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S1262-3636(07)70116-7","volume":"30","author":"F Guerrero-Romero","year":"2004","unstructured":"Guerrero-Romero, F. et al. Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial. Diabetes Metab. 30, 253\u2013258 (2004).","journal-title":"Diabetes Metab."},{"key":"18076_CR29","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2174\/1566524053766095","volume":"5","author":"D Ziegler","year":"2005","unstructured":"Ziegler, D. Type 2 diabetes as an inflammatory cardiovascular disorder. Curr. Mol. Med. 5, 309\u2013322 (2005).","journal-title":"Curr. Mol. Med."},{"key":"18076_CR30","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/ejcn.2014.7","volume":"68","author":"DT Dibaba","year":"2014","unstructured":"Dibaba, D. T., Xun, P. & He, K. Dietary magnesium intake is inversely associated with serum C-reactive protein levels: meta-analysis and systematic review. Eur. J. Clin. Nutr. 68, 510\u2013516 (2014).","journal-title":"Eur. J. Clin. Nutr."},{"key":"18076_CR31","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1177\/0884533608314533","volume":"23","author":"CM Champagne","year":"2008","unstructured":"Champagne, C. M. Magnesium in hypertension, cardiovascular disease, metabolic syndrome, and other conditions: a review. Nutr. Clin. Pract. Off. Publ. Am. Soc. Parenter. Enter. Nutr. 23, 142\u2013151 (2008).","journal-title":"Nutr. Clin. Pract. Off. Publ. Am. Soc. Parenter. Enter. Nutr."},{"key":"18076_CR32","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1161\/CIRCULATIONAHA.105.588327","volume":"113","author":"K He","year":"2006","unstructured":"He, K. et al. Magnesium intake and incidence of metabolic syndrome among young adults. Circulation 113, 1675\u20131682 (2006).","journal-title":"Circulation"},{"key":"18076_CR33","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1559-4564.2006.05702.x","volume":"1","author":"K He","year":"2006","unstructured":"He, K., Song, Y., Belin, R. J. & Chen, Y. Magnesium intake and the metabolic syndrome: epidemiologic evidence to date. J. Cardiometab. Syndr. 1, 351\u2013355 (2006).","journal-title":"J. Cardiometab. Syndr."},{"key":"18076_CR34","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.2337\/dc11-0518","volume":"34","author":"J-Y Dong","year":"2011","unstructured":"Dong, J.-Y., Xun, P., He, K. & Qin, L.-Q. Magnesium intake and risk of type 2 diabetes: meta-analysis of prospective cohort studies. Diabetes Care 34, 2116\u20132122 (2011).","journal-title":"Diabetes Care"},{"key":"18076_CR35","doi-asserted-by":"publisher","first-page":"134","DOI":"10.2337\/diacare.27.1.134","volume":"27","author":"R Lopez-Ridaura","year":"2004","unstructured":"Lopez-Ridaura, R. et al. Magnesium intake and risk of type 2 diabetes in men and women. Diabetes Care 27, 134\u2013140 (2004).","journal-title":"Diabetes Care"},{"key":"18076_CR36","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1365-2796.2007.01840.x","volume":"262","author":"SC Larsson","year":"2007","unstructured":"Larsson, S. C. & Wolk, A. Magnesium intake and risk of type 2 diabetes: a meta-analysis. J. Intern. Med. 262, 208\u2013214 (2007).","journal-title":"J. Intern. Med."},{"key":"18076_CR37","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1001\/archinte.167.9.956","volume":"167","author":"MB Schulze","year":"2007","unstructured":"Schulze, M. B. et al. Fiber and magnesium intake and incidence of type 2 diabetes: a prospective study and meta-analysis. Arch. Intern. Med. 167, 956\u2013965 (2007).","journal-title":"Arch. Intern. Med."},{"key":"18076_CR38","doi-asserted-by":"publisher","first-page":"e002111","DOI":"10.1136\/bmjopen-2012-002111","volume":"3","author":"Q Dai","year":"2013","unstructured":"Dai, Q. et al. Modifying effect of calcium\/magnesium intake ratio and mortality: a population-based cohort study. BMJ Open. 3, e002111 (2013).","journal-title":"BMJ Open."},{"key":"18076_CR39","doi-asserted-by":"crossref","unstructured":"Willett,W. Nutritional epidemiology (2nd ed). (Oxford University Press, 1998).","DOI":"10.1093\/acprof:oso\/9780195122978.001.0001"},{"key":"18076_CR40","unstructured":"Plan and operation of the Third National Health and Nutrition Examination Survey, 1988\u201394. Series 1: programs and collection procedures. Vital Health Stat. Ser 1 Programs Collect. Proced. 1\u2013407 (1994)."},{"key":"18076_CR41","unstructured":"NHANES 2003\u20132004: Dietary Interview-Individual Foods, First Day Data Documentation, Codebook, and Frequencies. Available at: http:\/\/wwwn.cdc.gov\/Nchs\/Nhanes\/2003-2004\/DR1IFF_C.htm. (Accessed: 4th November 2016)."},{"key":"18076_CR42","unstructured":"NHANES 1988\u20131994: Hepatic\/Gallbladder Ultrasound and Hepatic Steatosis Data Documentation, Codebook, and Frequencies. Available at: http:\/\/www.cdc.gov\/nchs\/nhanes\/nhanes3\/HGUHS.htm. (Accessed: 4th November 2016)."}],"updated-by":[{"DOI":"10.1038\/s41598-019-42590-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18076-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18076-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18076-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T17:08:03Z","timestamp":1671815283000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18076-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,20]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["18076"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-18076-5","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41598-019-42590-3","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,20]]},"assertion":[{"value":"4 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2019","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"17913"}}